Drospirenone And Ethinyl Estradiol Kit
Product Images NDC 50090-2594

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Drospirenone And Ethinyl Estradiol (NDC 50090-2594). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister.jpg (Blister)

A four-week calendar-style medication organizer diagram for drospirenone and ethinyl estradiol tablets, USP 3 mg/0.02 mg. The layout shows days of the week (Sunday to Saturday) across the top, with four rows labeled as Week 1 through Week 4. Circles indicate tablet locations for daily doses, guiding the user through the weekly sequence with arrows.*

FDA Label Image

Figure1.jpg (Figure1)

A forest plot chart depicting hazard ratios, rate ratios, and odds ratios from various studies including Ingenix, EURAS, LASS, FDA-funded study, Danish studies, MEGA, German case-control, PharMetrics, and GPRD. The chart compares these ratios across prospective and retrospective cohort studies, case-control studies, and non-fatal idiopathic cases, with a logarithmic scale ranging from 0.1 to 10 on the x-axis.*

FDA Label Image

Figure2.jpg (Figure2)

A horizontal bar chart showing the number of women with a blood clot per 10,000 women years for four categories: Non-Pregnant Non-COC user (1 to 5), COC-User (3 to 9), Pregnancy (5 to 20), and Postpartum (12 weeks only) (40 to 65). The chart compares clot incidence risks across these groups.*

FDA Label Image

Logo.jpg (Logo)

FDA Label Image

Structure-drospirenone.jpg (Structure Drospirenone)

Chemical structure diagram of the active ingredient drospirenone, showing its molecular framework with ketone groups and multiple rings as depicted in the image.*

FDA Label Image

Structure-ethinyl.jpg (Structure Ethinyl)

Chemical structure diagram of drospirenone and ethinyl estradiol, showing the molecular frameworks and bonds characteristic of these active ingredients.*

FDA Label Image

Chart (Chart)

A vertical chart comparing pregnancy rates per 100 women per year with different birth control methods. It ranks methods from fewer pregnancies at the top, including implants, injections, intrauterine devices, sterilization, and birth control pills, to more pregnancies at the bottom with no birth control. Intermediate methods include condoms, diaphragm, spermicide, withdrawal, and abstinence during fertile days.*

FDA Label Image

Label Image (Lbl500902594)

Packaging label for drospirenone and ethinyl estradiol kit by A-S Medication Solutions, NDC 50090-2594. It contains 28 tablets with a dosage of 3 mg drospirenone and 0.02 mg ethinyl estradiol per tablet. Storage instructions specify keeping the product at 8 to 30 degrees Celsius (46 to 86 degrees Fahrenheit).*

FDA Label Image

Serious-blood-clot (Serious Blood Clot)

A horizontal bar chart showing the number of women with a blood clot per 10,000 women years across four groups: Non-Pregnant Non-COC users (range 1 to 5), COC users (range 3 to 9), Pregnancy (range 5 to 20), and Postpartum (12 weeks only) with the highest range of 40 to 65. The chart includes a note explaining pregnancy duration assumptions for the pregnancy group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.